1-7 of 7
Anthony El-Khoueiry
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract IA19: Impact of single checkpoint inhibitors and biomarkers of response

Anthony El-Khoueiry
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (17_Supplement): IA19.
https://doi.org/10.1158/1557-3265.LIVERCA22-IA19
Published: 01 September 2022
View article titled, Abstract IA19: Impact of single checkpoint inhibitors and biomarkers of response
Journal Articles

Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies

Melissa Johnson, Anthony El-Khoueiry, Navid Hafez, Nehal Lakhani, Hirva Mamdani, Jordi Rodon, Rachel E. Sanborn, Javier Garcia-Corbacho, Valentina Boni, Mark Stroh, Alison L. Hannah, Song Wang, Henry Castro, Alexander Spira
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (16): 4521–4530.
https://doi.org/10.1158/1078-0432.CCR-21-0194
Published: 15 August 2021
View article titled, Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies
Open the PDF for Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor Malignancies in another window
Includes: Supplementary data
Journal Articles

A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer

Alex A. Adjei, Donald A. Richards, Anthony El-Khoueiry, Fadi Braiteh, Carlos H.R. Becerra, Joe J. Stephenson, Jr, Aram F. Hezel, Morris Sherman, Lawrence Garbo, Diane P. Leffingwell, Cory Iverson, Jeffrey N. Miner, Zancong Shen, Li-Tain Yeh, Sonny Gunawan, David M. Wilson, Kimberly J. Manhard, Prabhu Rajagopalan, Heiko Krissel, Neil J. Clendeninn
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (10): 2368–2376.
https://doi.org/10.1158/1078-0432.CCR-15-1681
Published: 12 May 2016
View article titled, A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer
Open the PDF for A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract A4: Identification of novel histone deacetylase inhibitor-regulated drug targets and a phase I/II trial of vorinostat in combination with 5-fluorouracil in metastatic colorectal cancer

Peter M. Wilson, Melissa J. LaBonte, Anthony El-Khoueiry, Heinz-Josef Lenz, Robert D. Ladner
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7_Supplement): A4.
https://doi.org/10.1158/1078-0432.TCME10-A4
Published: 02 February 2016
View article titled, Abstract A4: Identification of novel histone deacetylase inhibitor-regulated drug targets and a phase I/II trial of vorinostat in combination with 5-fluorouracil in metastatic colorectal cancer
Journal Articles

Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence

Armin Gerger, Wu Zhang, Dongyun Yang, Pierre Bohanes, Yan Ning, Thomas Winder, Melissa J. LaBonte, Peter M. Wilson, Leonor Benhaim, David Paez, Rita El-Khoueiry, Anthony El-Khoueiry, Michael Kahn, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (21): 6934–6943.
https://doi.org/10.1158/1078-0432.CCR-11-1180
Published: 31 October 2011
View article titled, Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence
Open the PDF for Common Cancer Stem Cell Gene Variants Predict Colon Cancer Recurrence in another window
Journal Articles

Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer

Armin Gerger, Anthony El-Khoueiry, Wu Zhang, Dongyun Yang, Harpreet Singh, Pierre Bohanes, Yan Ning, Thomas Winder, Melissa J. LaBonte, Peter M. Wilson, Leonor Benhaim, David Paez, Rita El-Khoueiry, Gudrun Absenger, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (17): 5783–5792.
https://doi.org/10.1158/1078-0432.CCR-11-1115
Published: 01 September 2011
View article titled, Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer
Open the PDF for Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Polymorphisms in Cyclooxygenase-2 and Epidermal Growth Factor Receptor Are Associated with Progression-Free Survival Independent of K-ras in Metastatic Colorectal Cancer Patients Treated with Single-Agent Cetuximab

Georg Lurje, Fumio Nagashima, Wu Zhang, Dongyun Yang, Heung M. Chang, Michael A. Gordon, Anthony El-Khoueiry, Hatim Husain, Peter M. Wilson, Robert D. Ladner, David J. Mauro, Christiane Langer, Eric K. Rowinsky, Heinz-Josef Lenz
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (23): 7884–7895.
https://doi.org/10.1158/1078-0432.CCR-07-5165
Published: 01 December 2008
View article titled, Polymorphisms in <em>Cyclooxygenase-2</em> and <em>Epidermal Growth Factor Receptor</em> Are Associated with Progression-Free Survival Independent of K-ras in Metastatic Colorectal Cancer Patients Treated with Single-Agent Cetuximab
Open the PDF for Polymorphisms in <em>Cyclooxygenase-2</em> and <em>Epidermal Growth Factor Receptor</em> Are Associated with Progression-Free Survival Independent of K-ras in Metastatic Colorectal Cancer Patients Treated with Single-Agent Cetuximab in another window